Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
liquid biopsy
MedTech
Roche leads Freenome's $254M fundraising for cancer blood tests
Roche has participated in all of Freenome’s past funding rounds and was also solely responsible for a $290 million contribution at the start of 2022.
Andrea Park
Feb 15, 2024 10:27am
Delfi debuts tumor-monitoring test alongside Immunocore collab
Feb 1, 2024 11:31am
Precede's liquid biopsy uncovers transcriptional cancer markers
Oct 23, 2023 2:50pm
EU orders Illumina to split from Grail as penance for $8B deal
Oct 12, 2023 11:14am
Delfi launches blood-based lung cancer screening test
Oct 9, 2023 8:00am
Dana-Farber's Precede debuts with $57M for blood biopsy tests
Oct 6, 2023 10:15am